Skip to content

Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits

Using Telemedicine to Prevent Blindness in an At-risk Rural Alabama Population

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04328207
Acronym
AL-SIGHT
Enrollment
900
Registered
2020-03-31
Start date
2020-11-18
Completion date
2024-07-01
Last updated
2025-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavior, Health, Cataract, Diabetic Retinopathy, Glaucoma, Refractive Errors

Keywords

telemedicine, teleophthalmology, telehealth, teleglaucoma, financial incentives

Brief summary

Glaucoma is a blinding eye disease increasingly common in older adults, particularly in African Americans, and often diagnosed late in the disease course. It is essential to develop novel health care models, utilizing telemedicine, to improve the ability to detect glaucoma at an earlier stage, and to provide a platform to manage this disease in community-based clinics so that further vision loss is prevented. Our goal is to improve the quality and accessibility of glaucoma detection and management among a vulnerable and at-risk segment of our population.

Detailed description

The number of primary open angle glaucoma (POAG) cases will increase by 250% by 2050, directly affecting over 7 million lives. These numbers are specifically for POAG and do not include the many who are monitored and treated for elevated intraocular pressure or for glaucoma suspect status, which along with POAG can all be considered glaucoma associated diseases (GAD). Development of high-quality, accessible, and cost-effective strategies for eye care for these individuals is of critical importance. POAG is at least 4-5 times higher in African Americans, progresses more rapidly and appears about 10 years earlier as compared to those of European descent. This research plan seeks to implement and evaluate a telemedicine-based detection and management strategy for GAD and other eye diseases in patients seen at Federally Qualified Health Centers (FQHC's) located in the rural Alabama Black Belt Region. This region is characterized by one of the highest concentrations of African Americans in the US; high poverty, unemployment, and uninsured rates; inadequate educational systems, transportation and community resources; few optometrists who largely practice in retail settings; and no ophthalmologists specializing in glaucoma. The investigators have developed and tested a novel multimodal telemedicine approach in a prior Centers for Disease Control and Prevention (CDC) funded Eye Care Quality and Accessibility Improvement in the Community (EQUALITY) study that used comprehensive remote optic nerve assessment (RONA). This proposal will employ a modification of the EQUALITY approach using portable measurement of visual function and optic nerve and retinal structure that are more applicable to rural locations with limited resources. The investigators will also identify and evaluate remediation strategies for the barriers to patient adherence with referral and follow-up appointments by comparing the effectiveness of financial incentives along with a validated patient education program versus a validated patient education program alone. Using this program within FQHC's will enable expansion nationwide into rural and urban underserved locations as these centers provide primary health care services in underserved areas and treat more than 27 million people yearly at over 12,000 sites.

Interventions

Standard of care eye health education

BEHAVIORALFinancial Incentive

Patients who are referred for an in-person follow-up exam will receive a financial incentive once the referral visit is completed.

Sponsors

Centers for Disease Control and Prevention
CollaboratorFED
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

The investigators are masked as to which group the patient is in.

Intervention model description

In the first half of enrollment in the program there will be no financial incentive offered to any patients. In the second half of enrollment, all patients needing referral will be notified that they will receive a payment upon the completion of their referral visit.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* African American or Hispanic ≥40 years * Non-Hispanic white ≥50 years * Anyone ≥ 18 years with diabetes * Anyone ≥ 18 years with a glaucoma associated diagnosis * Anyone ≥ 18 years with a family history of glaucoma * All enrollees must be able to speak and understand English

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants That Adhere to Referral AppointmentThe time frame will be whether they attended the referral appointment between the screening date until 6 months after the screening date.The percentage of patients who adhere to attending their referral appointments who received a financial incentive and eye health education will be compared with the percentage of patients who adhere to attending their referral appointments who received standard of care eye health education alone and no financial incentive for completing a referral visit.

Countries

United States

Participant flow

Participants by arm

ArmCount
No Financial Incentive
This group will receive standard of care eye health education alone and no financial incentive for completing a referral visit. No Financial Incentive: Standard of care eye health education
499
Financial Incentive
This group will receive a financial incentive once the referral visit is completed (if one was required) as well as eye health education. Financial Incentive: Patients who are referred for an in-person follow-up exam will receive a financial incentive once the referral visit is completed.
401
Total900

Baseline characteristics

CharacteristicNo Financial IncentiveFinancial IncentiveTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
227 Participants201 Participants428 Participants
Age, Categorical
Between 18 and 65 years
272 Participants200 Participants472 Participants
Age, Continuous58.49 years
STANDARD_DEVIATION 13.5
59.58 years
STANDARD_DEVIATION 11.99
58.97 years
STANDARD_DEVIATION 12.85
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants4 Participants7 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
496 Participants397 Participants893 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
228 Participants142 Participants370 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
14 Participants9 Participants23 Participants
Race (NIH/OMB)
White
257 Participants250 Participants507 Participants
Region of Enrollment
United States
499 participants401 participants900 participants
Sex: Female, Male
Female
322 Participants258 Participants580 Participants
Sex: Female, Male
Male
177 Participants143 Participants320 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 4990 / 401
other
Total, other adverse events
0 / 4990 / 401
serious
Total, serious adverse events
0 / 4990 / 401

Outcome results

Primary

Percentage of Participants That Adhere to Referral Appointment

The percentage of patients who adhere to attending their referral appointments who received a financial incentive and eye health education will be compared with the percentage of patients who adhere to attending their referral appointments who received standard of care eye health education alone and no financial incentive for completing a referral visit.

Time frame: The time frame will be whether they attended the referral appointment between the screening date until 6 months after the screening date.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
No Financial IncentivePercentage of Participants That Adhere to Referral Appointment80 Participants
Financial IncentivePercentage of Participants That Adhere to Referral Appointment92 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026